5-patient in-human Evaluation

World’s first 5-patient in-human evaluation of Augmented Reality guided tumor ablation completed at the Cleveland Clinic.

MediView AR, LLC,™ today announced the successful completion of the initial 5-patient in-human evaluation of its intraoperative Real-Time, Fused Holographic Visualization (RTFHV)™ Extended Reality Surgical Navigation System. MediView is an Ohio-based medical device startup company working to launch a stand-alone Extended Reality Surgical Navigation Platform for percutaneous soft tissue, organ and bone procedures.

Karl West, M.S., Inventor of the Technology and Director of Medical Device Solutions at Cleveland Clinic’s Lerner Research Institute stated: “The completion of this 5-patient in-human evaluation of the RTFHV™ Extended Reality Navigation is a tremendous leap forward in the evolution of surgical imaging technology.  RTFHV™ offers the ability to give surgeons the x-ray vision that was once the dreams of comic books.”

For this initial 5-patient series MediView’s RTFHV™System was evaluated in a series of liver tumor ablations. The procedures were completed by Dr. Charles Martin III, M.D., Director of Interventional Oncology at the Cleveland Clinic, as part of the safety and feasibility trial for the technology (Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation – clinicaltrials.gov).

Dr. Martin explained “MediView’s RTFHV™ Extended Reality surgical navigation system achieved proof-of-concept in a series of highly complex soft-tissue percutaneous liver tumor ablation procedures.  This revolutionary medical imaging technology has the potential to redefine the cancer care continuum and procedural navigation as we know it.”

Unlike standard procedural images that require doctors to rely on images displayed on a conventional 2D screen, MediView’s RTFHV™ system essentially gives physicians “x-ray vision.”  With MediView’s proprietary technology the surgeons can look directly at the patient, see beneath their skin, and peer into their internal anatomy during a procedure.  Throughout the procedure their surgical tools are tracked to the targeted anatomy with mini-GPS-like navigation.

“The potential benefits of extended reality assisted surgical procedures are exponential.  Existing surgical imaging modalities have limitations that reduce their effectiveness in percutaneous procedures and expose medical professionals to risks associated with radiation exposure, which MediView’s technology is specifically designed to overcome” said John W. Black, CEO and Co-Founder of MediView. “We are excited to partner with the lab at Cleveland Clinic’s Lerner Research Institute to design, test and refine this technology.”

Related posts:

Movers & Shakers: Adam Rakestraw on X-ray vision, building his own house and pivoting from law to medical tech MediView Recognized In The Medical Capital Innovation Competition MediView XR, Inc. Secures $15M Strategic Funding Round with Backing from Leading Collaborators across Clinical, Industry and Government Mediview Announces New Clinical Advisory Board Member (Jordan Tasse)